These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8687018)

  • 1. Fractionation of amyloid beta-protein (A beta) in Alzheimer's disease and Down's syndrome brains. Presence of membrane-bound A beta.
    Yanagisawa K; Asami-Odaka A; Suzuki N; Ihara Y
    Ann N Y Acad Sci; 1996 Jun; 786():184-94. PubMed ID: 8687018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1 ganglioside-bound amyloid beta-protein in Alzheimer's disease brain.
    Yanagisawa K; Ihara Y
    Neurobiol Aging; 1998; 19(1 Suppl):S65-7. PubMed ID: 9562471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype.
    Mann DM; Pickering-Brown SM; Siddons MA; Iwatsubo T; Ihara Y; Asami-Odaka A; Suzuki N
    Neurosci Lett; 1995 Aug; 196(1-2):105-8. PubMed ID: 7501233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical amyloid (A beta) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific A beta monoclonal antibodies.
    Mann DM; Iwatsubo T; Snowden JS
    Acta Neuropathol; 1996; 91(6):647-53. PubMed ID: 8781665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions.
    Wisniewski T; Lalowski M; Baumann M; Rauvala H; Raulo E; Nolo R; Frangione B
    Neuroreport; 1996 Jan; 7(2):667-71. PubMed ID: 8730853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of beta-amyloid protein deposited lesions in Down's syndrome brains.
    Ikeda S; Tokuda T; Yanagisawa N; Kametani F; Ohshima T; Allsop D
    Tohoku J Exp Med; 1994 Nov; 174(3):189-98. PubMed ID: 7761984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons.
    Wen GY; Wisniewski HM; Blondal H; Benedikz E; Frey H; Pirttila T; Rudelli R; Kim KS
    Acta Neuropathol; 1994; 88(3):201-6. PubMed ID: 7810290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques.
    Iwatsubo T; Saido TC; Mann DM; Lee VM; Trojanowski JQ
    Am J Pathol; 1996 Dec; 149(6):1823-30. PubMed ID: 8952519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain.
    Kida E; Wisniewski KE; Wisniewski HM
    Neurosci Lett; 1995 Jun; 193(2):105-8. PubMed ID: 7478152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
    Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques.
    Mann DM; Iwatsubo T; Fukumoto H; Ihara Y; Odaka A; Suzuki N
    Acta Neuropathol; 1995; 90(5):472-7. PubMed ID: 8560980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome.
    Cataldo AM; Barnett JL; Mann DM; Nixon RA
    J Neuropathol Exp Neurol; 1996 Jun; 55(6):704-15. PubMed ID: 8642396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.